Total planned funding: $391,828,679
Allocations
Countries/Regions
Eswatini | $391,828,679 |
Organizational Types
Private Contractor | $96,658,327 |
University | $73,251,731 |
Unknown | $68,050,788 |
NGO | $67,971,494 |
Own Agency | $47,940,084 |
Host Country Government Agency | $13,994,827 |
FBO | $13,230,009 |
Multi-lateral Agency | $7,432,970 |
Other USG Agency | $2,708,449 |
Implementing Agency | $590,000 |
Program Areas
Care | $118,526,636 |
Treatment | $95,183,343 |
Prevention | $75,170,383 |
Governance and Systems | $42,195,698 |
Management and Operations | $31,047,315 |
Testing | $29,705,304 |
Budget Codes
HTXS: Treatment: Adult Treatment | $75,904,630 |
HBHC: Care: Adult Care and Support | $49,838,352 |
HKID: Care: Orphans and Vulnerable Children | $39,130,996 |
HVMS: Management and Operations | $31,047,315 |
HVCT: Testing: HIV Testing and Counseling | $29,705,304 |
HVOP: Sexual Prevention: Other Sexual Prevention | $27,001,311 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,535,679 |
HVTB: Care: TB/HIV | $20,117,240 |
OHSS: Health Systems Strengthening | $18,142,946 |
HVSI: Strategic Information | $16,378,525 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $12,982,939 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,133,483 |
HTXD: Treatment: ARV Drugs | $10,828,150 |
PDCS: Care: Pediatric Care and Support | $9,440,048 |
PDTX: Treatment: Pediatric Treatment | $8,450,563 |
HLAB: Laboratory Infrastructure | $7,674,227 |
HMBL: Biomedical Prevention: Blood Safety | $1,516,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$63,668,355
Countries/Regions
Not Available:
$49,590,922
Countries/Regions
Pact, Inc.:
$45,675,220
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions